Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 22, Pages -Publisher
MDPI
DOI: 10.3390/ijms21228569
Keywords
wound healing; secretome; osteoclastogenesis; macrophages; apoptosis; necroptosis; periodontitis
Funding
- Austrian Science Fund (FWF) [4072-B28]
- Vienna Business Agency (Vienna, Austria) [2343727]
Ask authors/readers for more resources
Osteoclastogenesis required for bone remodeling is also a key pathologic mechanism of inflammatory osteolysis being controlled by paracrine factors released from dying cells. The secretome of irradiated, dying peripheral blood mononuclear cells (PBMCs) has a major impact on the differentiation of myeloid cells into dendritic cells, and macrophage polarization. The impact on osteoclastogenesis, however, has not been reported. For this aim, we used murine bone marrow macrophages exposed to RANKL and M-CSF to initiate osteoclastogenesis, with and without the secretome obtained from gamma-irradiated PBMCs. We reported that the secretome significantly enhanced in vitro osteoclastogenesis as determined by means of histochemical staining of the tartrate-resistant acid phosphatase (TRAP), as well as the expression of the respective target genes, including TRAP and cathepsin K. Considering that TGF-beta enhanced osteoclastogenesis, we confirmed the TGF-beta activity in the secretome with a bioassay that was based on the increased expression of IL11 in fibroblasts. Neutralizing TGF-beta by an antibody decreased the ability of the secretome to support osteoclastogenesis. These findings suggested that TGF-beta released by irradiated PBMCs could enhance the process of osteoclastogenesis in vitro.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available